Ivermectin and malaria control
- PMID: 28438169
- PMCID: PMC5404691
- DOI: 10.1186/s12936-017-1825-9
Ivermectin and malaria control
Abstract
As the world begins to realize the very real prospect of eliminating malaria as a public health problem globally, the scientific community is acutely aware that novel and innovative new tools will be required if that lofty goal is to be accomplished. Moreover, the need for comprehensive, integrated products and interventions is being recognized in order for the critical 'final steps' toward elimination to be taken successfully. Failure to take these crucial last steps have dogged all past global disease elimination programmes, except for smallpox. The success of ivermectin in driving two of the most devastating and disfiguring neglected tropical diseases (NTD) to the brink of elimination has been well documented. The drug also bestows immeasurable non-target benefits, increasing the health and socioeconomic prospects of all communities where mass drug administration (MDA) has been carried out. Ivermectin kills a variety of parasites and insects, including the Anopheline vectors of malaria parasites. In view of long-standing MDA programmes, increasing attention is now being paid to the potential offered by re-formulating and re-purposing ivermectin to function as a feed-though mosquitocidal tool. This will provide a comprehensively beneficial weapon, for the anti-malarial armamentarium, as well as for probably improving the impact on existing target diseases. Prospects currently look highly promising, especially as the drug is already proven to be extremely safe for human use. However, for maximum impact, detailed analysis of various analogues of the unique ivermectin, as well as the parent avermectin compounds, will need to be undertaken. 'Ivermectin' comprises an imprecise mix of two compounds, both of which are potent anthelmintics. Yet recently, it has been confirmed that only the minor of the two component compounds is molluscicidal. Further structure activity relationship studies may well identify the analogue, analogues or combination thereof best suited for use in a concerted initiative to simultaneously tackle malaria and other NTD in poly-parasitized communities.
Keywords: Feed-through insecticide; Ivermectin; Malaria.
Similar articles
-
Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria.Malar J. 2017 Apr 24;16(1):168. doi: 10.1186/s12936-017-1830-z. Malar J. 2017. PMID: 28438168 Free PMC article.
-
Ivermectin: a complimentary weapon against the spread of malaria?Expert Rev Anti Infect Ther. 2017 Mar;15(3):231-240. doi: 10.1080/14787210.2017.1271713. Epub 2016 Dec 29. Expert Rev Anti Infect Ther. 2017. PMID: 27960597 Free PMC article. Review.
-
Broadening the range of use cases for ivermectin - a review of the evidence.Trans R Soc Trop Med Hyg. 2022 Mar 2;116(3):201-212. doi: 10.1093/trstmh/trab114. Trans R Soc Trop Med Hyg. 2022. PMID: 34323283 Free PMC article. Review.
-
Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages.Am J Trop Med Hyg. 2011 Jul;85(1):3-5. doi: 10.4269/ajtmh.2011.11-0160. Am J Trop Med Hyg. 2011. PMID: 21734116 Free PMC article.
-
Ivermectin: A Promising Therapeutic for Fighting Malaria. Current Status and Perspective.J Med Chem. 2021 Jul 22;64(14):9711-9731. doi: 10.1021/acs.jmedchem.1c00498. Epub 2021 Jul 9. J Med Chem. 2021. PMID: 34242031 Review.
Cited by
-
A Microsatellite Multiplex Assay for Profiling Pig DNA in Mosquito Bloodmeals.J Med Entomol. 2019 Jun 27;56(4):907-914. doi: 10.1093/jme/tjz013. J Med Entomol. 2019. PMID: 30768665 Free PMC article.
-
Evaluation of the inhibitory effect of ivermectin on the growth of Babesia and Theileria parasites in vitro and in vivo.Trop Med Health. 2019 Jul 11;47:42. doi: 10.1186/s41182-019-0171-8. eCollection 2019. Trop Med Health. 2019. PMID: 31337949 Free PMC article.
-
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota.Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):372-378. doi: 10.1016/j.ijpddr.2018.07.001. Epub 2018 Jul 2. Int J Parasitol Drugs Drug Resist. 2018. PMID: 30007544 Free PMC article.
-
A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria.Malar J. 2018 Dec 10;17(1):462. doi: 10.1186/s12936-018-2598-5. Malar J. 2018. PMID: 30526594 Free PMC article. Review.
-
In vitro anti-trypanosomal effect of ivermectin on Trypanosoma evansi by targeting multiple metabolic pathways.Trop Anim Health Prod. 2022 Jul 22;54(4):240. doi: 10.1007/s11250-022-03228-1. Trop Anim Health Prod. 2022. PMID: 35869164 Free PMC article.
References
-
- Ōmura S, Crump A. The life and times of ivermectin: a success story. Nat Rev Microbiol. 2005;2:984–989. - PubMed
-
- WHO. Update on the global status of implementation of preventive chemotherapy. (PC); 8th March 2017. Accessed 9 Mar 2017.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous